nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—bone cancer	0.95	1	CbGaD
Desvenlafaxine—Venlafaxine—CYP3A4—bone cancer	0.00191	1	CrCbGaD
Desvenlafaxine—Interstitial lung disease—Methotrexate—bone cancer	0.000661	0.0138	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Cisplatin—bone cancer	0.000621	0.013	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000619	0.0129	CcSEcCtD
Desvenlafaxine—Irritability—Cisplatin—bone cancer	0.00059	0.0124	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Cisplatin—bone cancer	0.000565	0.0118	CcSEcCtD
Desvenlafaxine—Breast disorder—Cisplatin—bone cancer	0.000559	0.0117	CcSEcCtD
Desvenlafaxine—Proteinuria—Methotrexate—bone cancer	0.000532	0.0111	CcSEcCtD
Desvenlafaxine—Protein urine present—Methotrexate—bone cancer	0.000525	0.011	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Methotrexate—bone cancer	0.000521	0.0109	CcSEcCtD
Desvenlafaxine—Bone disorder—Methotrexate—bone cancer	0.000518	0.0108	CcSEcCtD
Desvenlafaxine—Bone disorder—Epirubicin—bone cancer	0.000484	0.0101	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Cisplatin—bone cancer	0.00047	0.00983	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Cisplatin—bone cancer	0.000467	0.00978	CcSEcCtD
Desvenlafaxine—Bone disorder—Doxorubicin—bone cancer	0.000448	0.00938	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Epirubicin—bone cancer	0.000432	0.00905	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Cisplatin—bone cancer	0.000423	0.00884	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Cisplatin—bone cancer	0.00042	0.0088	CcSEcCtD
Desvenlafaxine—Urethral disorder—Cisplatin—bone cancer	0.000419	0.00878	CcSEcCtD
Desvenlafaxine—Abnormal dreams—Doxorubicin—bone cancer	0.0004	0.00837	CcSEcCtD
Desvenlafaxine—Eye disorder—Cisplatin—bone cancer	0.0004	0.00837	CcSEcCtD
Desvenlafaxine—Tinnitus—Cisplatin—bone cancer	0.000399	0.00835	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Cisplatin—bone cancer	0.000397	0.00831	CcSEcCtD
Desvenlafaxine—Immune system disorder—Cisplatin—bone cancer	0.000386	0.00809	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Cisplatin—bone cancer	0.000386	0.00807	CcSEcCtD
Desvenlafaxine—Alopecia—Cisplatin—bone cancer	0.000378	0.00791	CcSEcCtD
Desvenlafaxine—Malnutrition—Cisplatin—bone cancer	0.000372	0.00779	CcSEcCtD
Desvenlafaxine—Vision blurred—Cisplatin—bone cancer	0.000351	0.00735	CcSEcCtD
Desvenlafaxine—Tremor—Cisplatin—bone cancer	0.000349	0.0073	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—bone cancer	0.00034	0.00711	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—bone cancer	0.000337	0.00704	CcSEcCtD
Desvenlafaxine—Irritability—Methotrexate—bone cancer	0.000324	0.00678	CcSEcCtD
Desvenlafaxine—Convulsion—Cisplatin—bone cancer	0.000323	0.00675	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—bone cancer	0.000319	0.00667	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000318	0.00665	CcSEcCtD
Desvenlafaxine—Anxiety—Cisplatin—bone cancer	0.000316	0.00661	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000315	0.00659	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—bone cancer	0.000314	0.00657	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Methotrexate—bone cancer	0.000313	0.00656	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—bone cancer	0.000311	0.00652	CcSEcCtD
Desvenlafaxine—Breast disorder—Methotrexate—bone cancer	0.000307	0.00642	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000306	0.0064	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Cisplatin—bone cancer	0.000298	0.00624	CcSEcCtD
Desvenlafaxine—Tachycardia—Cisplatin—bone cancer	0.000297	0.00621	CcSEcCtD
Desvenlafaxine—Skin disorder—Cisplatin—bone cancer	0.000295	0.00618	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—bone cancer	0.000295	0.00617	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000294	0.00615	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Cisplatin—bone cancer	0.000294	0.00615	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—bone cancer	0.000293	0.00614	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—bone cancer	0.00029	0.00607	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—bone cancer	0.000287	0.00601	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000286	0.00599	CcSEcCtD
Desvenlafaxine—Paraesthesia—Cisplatin—bone cancer	0.000273	0.00571	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—bone cancer	0.000271	0.00568	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—bone cancer	0.00027	0.00565	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000268	0.00562	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—bone cancer	0.000268	0.0056	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—bone cancer	0.000266	0.00556	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000265	0.00554	CcSEcCtD
Desvenlafaxine—Decreased appetite—Cisplatin—bone cancer	0.000264	0.00553	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000262	0.00549	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000259	0.00543	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—bone cancer	0.000251	0.00524	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—bone cancer	0.00025	0.00523	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—bone cancer	0.000248	0.0052	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—bone cancer	0.000247	0.00516	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000243	0.00508	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—bone cancer	0.000232	0.00485	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000232	0.00485	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—bone cancer	0.000231	0.00484	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—bone cancer	0.000231	0.00483	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—bone cancer	0.00023	0.00482	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—bone cancer	0.00023	0.00481	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000225	0.0047	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Cisplatin—bone cancer	0.000224	0.00469	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—bone cancer	0.000222	0.00465	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—bone cancer	0.000219	0.00459	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—bone cancer	0.000219	0.00458	CcSEcCtD
Desvenlafaxine—Asthenia—Cisplatin—bone cancer	0.000218	0.00456	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—bone cancer	0.000218	0.00456	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—bone cancer	0.000217	0.00454	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—bone cancer	0.000216	0.00452	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—bone cancer	0.000215	0.00451	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—bone cancer	0.000214	0.00447	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—bone cancer	0.000213	0.00446	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—bone cancer	0.000212	0.00444	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—bone cancer	0.000212	0.00443	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—bone cancer	0.000211	0.00441	CcSEcCtD
Desvenlafaxine—Diarrhoea—Cisplatin—bone cancer	0.000208	0.00435	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—bone cancer	0.000208	0.00435	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—bone cancer	0.000207	0.00434	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—bone cancer	0.000206	0.0043	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—bone cancer	0.000205	0.0043	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—bone cancer	0.000205	0.00429	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—bone cancer	0.000204	0.00428	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—bone cancer	0.000204	0.00427	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—bone cancer	0.000201	0.0042	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—bone cancer	0.0002	0.00419	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—bone cancer	0.0002	0.00418	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—bone cancer	0.000199	0.00417	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—bone cancer	0.000199	0.00417	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—bone cancer	0.000198	0.00415	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—bone cancer	0.000198	0.00414	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—bone cancer	0.000197	0.00413	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—bone cancer	0.000194	0.00406	CcSEcCtD
Desvenlafaxine—Vomiting—Cisplatin—bone cancer	0.000193	0.00404	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—bone cancer	0.000193	0.00403	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—bone cancer	0.000193	0.00403	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—bone cancer	0.000192	0.00402	CcSEcCtD
Desvenlafaxine—Rash—Cisplatin—bone cancer	0.000192	0.00401	CcSEcCtD
Desvenlafaxine—Dermatitis—Cisplatin—bone cancer	0.000192	0.00401	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—bone cancer	0.000191	0.004	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—bone cancer	0.00019	0.00398	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—bone cancer	0.00019	0.00397	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—bone cancer	0.000189	0.00395	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—bone cancer	0.000188	0.00393	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—bone cancer	0.000187	0.00392	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—bone cancer	0.000186	0.00389	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—bone cancer	0.000184	0.00386	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—bone cancer	0.000184	0.00384	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—bone cancer	0.000184	0.00384	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—bone cancer	0.000183	0.00383	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—bone cancer	0.000182	0.00382	CcSEcCtD
Desvenlafaxine—Nausea—Cisplatin—bone cancer	0.000181	0.00378	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—bone cancer	0.00018	0.00377	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—bone cancer	0.00018	0.00376	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—bone cancer	0.000178	0.00373	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—bone cancer	0.000177	0.00371	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—bone cancer	0.000177	0.0037	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—bone cancer	0.000174	0.00363	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—bone cancer	0.000173	0.00363	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000173	0.00362	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—bone cancer	0.000172	0.0036	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—bone cancer	0.000172	0.0036	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—bone cancer	0.000172	0.00359	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—bone cancer	0.000169	0.00354	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—bone cancer	0.000168	0.00352	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—bone cancer	0.000167	0.00349	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—bone cancer	0.000166	0.00347	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—bone cancer	0.000165	0.00346	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—bone cancer	0.000164	0.00342	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—bone cancer	0.000162	0.0034	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—bone cancer	0.000162	0.00339	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000162	0.00338	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—bone cancer	0.000161	0.00337	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—bone cancer	0.000159	0.00333	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—bone cancer	0.000159	0.00333	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—bone cancer	0.000159	0.00332	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—bone cancer	0.000156	0.00327	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—bone cancer	0.000156	0.00326	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—bone cancer	0.000154	0.00321	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—bone cancer	0.000153	0.00321	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—bone cancer	0.000153	0.0032	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—bone cancer	0.000153	0.0032	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—bone cancer	0.000152	0.00319	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—bone cancer	0.000152	0.00317	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—bone cancer	0.000151	0.00316	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—bone cancer	0.000151	0.00316	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—bone cancer	0.00015	0.00314	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—bone cancer	0.00015	0.00313	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00015	0.00313	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—bone cancer	0.000148	0.0031	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—bone cancer	0.000147	0.00308	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—bone cancer	0.000145	0.00303	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000144	0.00301	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—bone cancer	0.000144	0.00301	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—bone cancer	0.000142	0.00297	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—bone cancer	0.000142	0.00296	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—bone cancer	0.000141	0.00295	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—bone cancer	0.000141	0.00295	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—bone cancer	0.00014	0.00294	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—bone cancer	0.00014	0.00293	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—bone cancer	0.00014	0.00292	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—bone cancer	0.000139	0.0029	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—bone cancer	0.000136	0.00284	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000135	0.00282	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—bone cancer	0.000135	0.00282	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—bone cancer	0.000134	0.00279	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—bone cancer	0.000131	0.00273	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—bone cancer	0.00013	0.00271	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—bone cancer	0.000128	0.00269	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—bone cancer	0.000126	0.00263	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000125	0.00261	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—bone cancer	0.000125	0.00261	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—bone cancer	0.000124	0.00258	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—bone cancer	0.000123	0.00257	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—bone cancer	0.00012	0.0025	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—bone cancer	0.000115	0.00241	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—bone cancer	0.000114	0.00239	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—bone cancer	0.000112	0.00234	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—bone cancer	0.00011	0.00231	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—bone cancer	0.000107	0.00224	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—bone cancer	0.000106	0.00223	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—bone cancer	0.000106	0.00222	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—bone cancer	0.000105	0.0022	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—bone cancer	0.000105	0.0022	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—bone cancer	0.000105	0.00219	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—bone cancer	0.000104	0.00217	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—bone cancer	0.000103	0.00216	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—bone cancer	9.93e-05	0.00208	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—bone cancer	9.91e-05	0.00207	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—bone cancer	9.88e-05	0.00207	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—bone cancer	9.84e-05	0.00206	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—bone cancer	9.83e-05	0.00206	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—bone cancer	9.78e-05	0.00205	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—bone cancer	9.55e-05	0.002	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—bone cancer	9.27e-05	0.00194	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—bone cancer	9.18e-05	0.00192	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—bone cancer	9.11e-05	0.00191	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—bone cancer	9.1e-05	0.0019	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—bone cancer	9.05e-05	0.00189	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—bone cancer	8.58e-05	0.0018	CcSEcCtD
